Form 8-K - Current report:
SEC Accession No. 0001437749-24-034347
Filing Date
2024-11-12
Accepted
2024-11-12 08:47:27
Documents
15
Period of Report
2024-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20241106_8k.htm   iXBRL 8-K 30595
2 EXHIBIT 10.1 ex_744301.htm EX-10.1 105740
  Complete submission text file 0001437749-24-034347.txt   296431

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyai-20241108.xsd EX-101.SCH 3411
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20241108_def.xml EX-101.DEF 11426
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20241108_lab.xml EX-101.LAB 15312
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20241108_pre.xml EX-101.PRE 11586
17 EXTRACTED XBRL INSTANCE DOCUMENT dyai20241106_8k_htm.xml XML 2845
Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 241443842
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)